Biden to designate two new national monuments, in Nevada and Texas
The Spirit Mountain area, also known as Avi Kwa Ame, would be the largest protected area so far under the Biden administration.
Abortion pill mifepristone ruling in Texas case could hinge on 1873 Comstock Act
Federal Judge Matthew Kacsmaryk raised the Comstock Act repeatedly in last week’s hearing for the case challenging FDA approval of mifepristone.
Watch Treasury Secretary Janet Yellen speak live to banking conference
Yellen said authorities are prepared to extend unlimited deposit insurance to other banks if necessary.
Ford reveals new Explorer EV for the European market
Other than the Explorer name and some design attributes, the new electric vehicle shares little to nothing with the gas-powered SUV in the U.S.
Op-ed: ESG investing and 2018 change in bank laws didn’t cause Silicon Valley Bank to collapse, says former Sen. Heitkamp
Former U.S. Sen. Heidi Heitkamp argues Democrats and Republicans have been too quick to place political blame after Silicon Valley Bank’s collapse.
Dodge resurrects controversial Challenger SRT Demon for final year of V8 muscle cars
The 2023 Dodge Challenger SRT Demon 170 will deliver 1,025 total horsepower, 945 foot-pounds of torque and reach 60 mph from a rolling start in 1.66 seconds.
Amazon’s post-Bezos experiment hasn’t gone exactly as planned
Andy Jassy’s tenure as Amazon CEO has been rocky and isn’t getting any easier after the company’s latest round of job cuts.
Biden signs legislation to declassify certain intelligence on Covid pandemic origins
Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.
Mortgage giant Fannie Mae tackles climate risk, but changes to underwriting may take several years
The mortgage industry is now trying to factor climate risk into its residential underwriting, but the task is enormous and complicated.
FDA staff says Biogen’s ALS drug may have a ‘clinical benefit’ on a rare form of the disease
The FDA staff on Monday said Biogen’s investigational ALS drug tofersen may have a “clinical benefit” on a rare and aggressive form of the disease.
